日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Chinese scholars publish biologics guideline in international journal

By Chen Meiling | chinadaily.com.cn | Updated: 2025-05-07 20:26
Share
Share - WeChat

A Chinese guideline on the use of biologic agents in treating chronic rhinosinusitis with nasal polyps was recently published in the 2025 China Issue of Allergy, one of the most prestigious journals in the global fields of allergology and clinical immunology.

It focuses on China-specific clinical data, systematically standardizing key aspects of biologic treatment, such as patient selection, therapeutic protocols and efficacy evaluation, providing authoritative guidance for clinical practice.

"Emerging biologics that selectively target key cytokines present a promising therapeutic alternative for patients suffering from severe, uncontrollable chronic rhinosinusitis with nasal polyps," according to the guideline.

It's the first time that Chinese scholars have published a guideline-type document in a top-tier international journal in this field, offering valuable Chinese experience for global biologic applications, said Zhang Luo, president of Beijing Tongren Hospital and guest editor of the issue, at a news conference in Beijing on Wednesday.

"In the last two decades, the problems of allergic diseases have been increasing dramatically in the world. Now we are facing 2 billion patients with allergic diseases, so this is a serious threat to humankind in the future," he said.

"In the past, we primarily relied on nasal corticosteroid sprays and oral antihistamines, both of which are chemical-based medications. These treatments have been widely used and can effectively control symptoms. However, since they require frequent administration (often daily), patients may find them inconvenient. Now, with these new biologics, just about three injections over an allergy season can effectively manage symptoms. In terms of both efficacy and duration of effect, they represent an improvement over traditional treatments," Zhang said.

He said these medicines are now available in major hospitals, such as in his hospital. However, since biologics are relatively new, their cost remains high — for example, a single injection may cost around 1,000 to 2,000 yuan ($138-276). "But as their use becomes more widespread, prices are expected to gradually decrease, making them more accessible to a larger number of patients," he added.

The 2025 China Issue of Allergy includes 32 articles focusing on the latest research progress of Chinese scholars in areas such as the link between environmental pollution and asthma pathogenesis, gut microbiota dysbiosis and allergies, as well as the mechanisms underlying drug hypersensitivity.

Cezmi Akdis, editor-in-chief of the journal Allergy, the official journal of the European Academy of Allergy and Clinical Immunology, praised China's contribution to the study of allergy, which has "immensely increased" in the last two decades.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 特黄级 | 日日a.v拍夜夜添久久免费 | 日本在线观看视频网站 | 久久精品一区二区三区不卡牛牛 | 一区二区三区视频在线播放 | 新视觉yy6080午夜毛片 | 国产色网 | 欧美一区在线观看视频 | 亚洲国产午夜电影在线入口 | 青青在线香蕉精品视频免费看 | 一区二区中文 | 国产成人精品免费视频大全可播放的 | 成人免费xxxxx在线观看 | 久久99精品久久 | 久久精品国产99久久6动漫亮点 | 成人免费看黄网站无遮挡 | 激情视频免费看 | 精品国产视频 | 波多野结衣在线免费 | 欧美人成片免费看视频不卡 | 国产精品久久久久久久免费 | 成人性视频免费网站 | 久久久www成人免费无遮挡大片 | 国产精品永久免费视频观看 | a在线免费观看 | 67194国产精品免费观看 | 亚洲国产综合精品 | 手机看片国产日韩 | 中文字幕av网 | 日韩黄色一级视频 | av毛片在线免费看 | 欧美精品导航 | 加勒比色综合 | 全日本爽视频在线 | wwwwxxxx免费 | 一级毛片在线免费观看 | 奇米影音四色 | 久草福利在线视频 | 精品一区视频 | 特级毛片免费观看视频 | 亚洲成a人片在线网站 |